ArticleBrain tumor pathology2026

CDKN2A deletion associated with poor prognosis in patients with TERT promoter wild-type, IDH wild-type glioblastoma.

Shigeru Kamimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.